Lynch Syndrome Caused by Germline PMS2 Mutations: Delineating the Cancer Risk

S.W. ten Broeke, R.M. Brohet, C.M. Tops, H.M. van der Klift, M.E. Velthuizen, I. Bernstein, G.C. Munar, E.G. Garcia, N. Hoogerbrugge, T.G.W. Letteboer, F.H. Menko, A. Lindblom, A.R. Mensenkamp, P. Moller, T.A. Os, N. Rahner, B.J.W. Redeker, R.H. Sijmons, L. Spruijt, M. Suerink & 6 others Y.J. Vos, A. Wagner, F.J. Hes, HF Vasen, M. Nielsen, J.T. Wijnen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)319-325
JournalJournal of Clinical Oncology
Volume33
Issue number4
DOIs
Publication statusPublished - 2015

Cite this

ten Broeke, S. W., Brohet, R. M., Tops, C. M., van der Klift, H. M., Velthuizen, M. E., Bernstein, I., ... Wijnen, J. T. (2015). Lynch Syndrome Caused by Germline PMS2 Mutations: Delineating the Cancer Risk. Journal of Clinical Oncology, 33(4), 319-325. https://doi.org/10.1200/JCO.2014.57.8088
ten Broeke, S.W. ; Brohet, R.M. ; Tops, C.M. ; van der Klift, H.M. ; Velthuizen, M.E. ; Bernstein, I. ; Munar, G.C. ; Garcia, E.G. ; Hoogerbrugge, N. ; Letteboer, T.G.W. ; Menko, F.H. ; Lindblom, A. ; Mensenkamp, A.R. ; Moller, P. ; Os, T.A. ; Rahner, N. ; Redeker, B.J.W. ; Sijmons, R.H. ; Spruijt, L. ; Suerink, M. ; Vos, Y.J. ; Wagner, A. ; Hes, F.J. ; Vasen, HF ; Nielsen, M. ; Wijnen, J.T. / Lynch Syndrome Caused by Germline PMS2 Mutations: Delineating the Cancer Risk. In: Journal of Clinical Oncology. 2015 ; Vol. 33, No. 4. pp. 319-325.
@article{1cc45a83acb94f1fbe73e2a3e2187486,
title = "Lynch Syndrome Caused by Germline PMS2 Mutations: Delineating the Cancer Risk",
author = "{ten Broeke}, S.W. and R.M. Brohet and C.M. Tops and {van der Klift}, H.M. and M.E. Velthuizen and I. Bernstein and G.C. Munar and E.G. Garcia and N. Hoogerbrugge and T.G.W. Letteboer and F.H. Menko and A. Lindblom and A.R. Mensenkamp and P. Moller and T.A. Os and N. Rahner and B.J.W. Redeker and R.H. Sijmons and L. Spruijt and M. Suerink and Y.J. Vos and A. Wagner and F.J. Hes and HF Vasen and M. Nielsen and J.T. Wijnen",
year = "2015",
doi = "10.1200/JCO.2014.57.8088",
language = "Undefined/Unknown",
volume = "33",
pages = "319--325",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "4",

}

ten Broeke, SW, Brohet, RM, Tops, CM, van der Klift, HM, Velthuizen, ME, Bernstein, I, Munar, GC, Garcia, EG, Hoogerbrugge, N, Letteboer, TGW, Menko, FH, Lindblom, A, Mensenkamp, AR, Moller, P, Os, TA, Rahner, N, Redeker, BJW, Sijmons, RH, Spruijt, L, Suerink, M, Vos, YJ, Wagner, A, Hes, FJ, Vasen, HF, Nielsen, M & Wijnen, JT 2015, 'Lynch Syndrome Caused by Germline PMS2 Mutations: Delineating the Cancer Risk' Journal of Clinical Oncology, vol. 33, no. 4, pp. 319-325. https://doi.org/10.1200/JCO.2014.57.8088

Lynch Syndrome Caused by Germline PMS2 Mutations: Delineating the Cancer Risk. / ten Broeke, S.W.; Brohet, R.M.; Tops, C.M.; van der Klift, H.M.; Velthuizen, M.E.; Bernstein, I.; Munar, G.C.; Garcia, E.G.; Hoogerbrugge, N.; Letteboer, T.G.W.; Menko, F.H.; Lindblom, A.; Mensenkamp, A.R.; Moller, P.; Os, T.A.; Rahner, N.; Redeker, B.J.W.; Sijmons, R.H.; Spruijt, L.; Suerink, M.; Vos, Y.J.; Wagner, A.; Hes, F.J.; Vasen, HF; Nielsen, M.; Wijnen, J.T.

In: Journal of Clinical Oncology, Vol. 33, No. 4, 2015, p. 319-325.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Lynch Syndrome Caused by Germline PMS2 Mutations: Delineating the Cancer Risk

AU - ten Broeke, S.W.

AU - Brohet, R.M.

AU - Tops, C.M.

AU - van der Klift, H.M.

AU - Velthuizen, M.E.

AU - Bernstein, I.

AU - Munar, G.C.

AU - Garcia, E.G.

AU - Hoogerbrugge, N.

AU - Letteboer, T.G.W.

AU - Menko, F.H.

AU - Lindblom, A.

AU - Mensenkamp, A.R.

AU - Moller, P.

AU - Os, T.A.

AU - Rahner, N.

AU - Redeker, B.J.W.

AU - Sijmons, R.H.

AU - Spruijt, L.

AU - Suerink, M.

AU - Vos, Y.J.

AU - Wagner, A.

AU - Hes, F.J.

AU - Vasen, HF

AU - Nielsen, M.

AU - Wijnen, J.T.

PY - 2015

Y1 - 2015

U2 - 10.1200/JCO.2014.57.8088

DO - 10.1200/JCO.2014.57.8088

M3 - Article

VL - 33

SP - 319

EP - 325

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 4

ER -

ten Broeke SW, Brohet RM, Tops CM, van der Klift HM, Velthuizen ME, Bernstein I et al. Lynch Syndrome Caused by Germline PMS2 Mutations: Delineating the Cancer Risk. Journal of Clinical Oncology. 2015;33(4):319-325. https://doi.org/10.1200/JCO.2014.57.8088